CVE-2026-28470OpenClaw versions prior to 2026.2.2 contain an exec approvals (must be enabled) allowlist bypass vulnerability that allows attackers to execute arbitrary commands by injecting command substitution sy…
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw versions prior to 2026.2.2 contain an exec approvals (must be enabled) allowlist bypass vulnerability that allows attackers to execute arbitrary commands by injecting command substitution syntax. Attackers can bypass the allowlist protection by embedding unescaped $() or backticks inside double-quoted strings to execute unauthorized commands.
- CVSS
- 9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-78
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Modified
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | before 2026.2.2 | NVD |
References
- https://github.com/openclaw/openclaw/commit/d1ecb46076145deb188abcba8f0699709ea17198patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-3hcm-ggvf-rch5vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-exec-allowlist-bypass-via-command-substitution-in-double-quotesthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.